154 results on '"Hayashi, Kazumi"'
Search Results
2. Non-pharmacological treatments for anticipatory nausea and vomiting during chemotherapy: a systematic review and meta-analysis of the Clinical Practice Guidelines for Antiemesis 2023
3. Long-term outcomes of oligometastatic breast cancer patients treated with curative intent: an updated report
4. Therapeutic effects of interleukin-1 receptor-associated kinase 4 inhibitor AS2444697 on diabetic nephropathy in type 2 diabetic mice
5. Claudin 7 as a possible novel molecular target for the treatment of pancreatic cancer
6. Supplementary Figure S1 from Treatment with Chemotherapy and Dendritic Cells Pulsed with Multiple Wilms' Tumor 1 (WT1)–Specific MHC Class I/II–Restricted Epitopes for Pancreatic Cancer
7. Supplementary Table S1 from Treatment with Chemotherapy and Dendritic Cells Pulsed with Multiple Wilms' Tumor 1 (WT1)–Specific MHC Class I/II–Restricted Epitopes for Pancreatic Cancer
8. Phase I/II trial of combination of temozolomide chemotherapy and immunotherapy with fusions of dendritic and glioma cells in patients with glioblastoma
9. Nafamostat mesilate, a serine protease inhibitor, suppresses interferon-gamma-induced up-regulation of programmed cell death ligand 1 in human cancer cells
10. Renoprotective effects of novel interleukin-1 receptor-associated kinase 4 inhibitor AS2444697 through anti-inflammatory action in 5/6 nephrectomized rats
11. Vaccination with vascular progenitor cells derived from induced pluripotent stem cells elicits antitumor immunity targeting vascular and tumor cells
12. Gemcitabine treatment enhances HER2 expression in low HER2-expressing breast cancer cells and enhances the antitumor effects of trastuzumab emtansine
13. A Retrospective Analysis of Perioperative Chemotherapy and Coronavirus Disease in Patients With Breast Cancer
14. 治癒を目指した治療を行った少数転移乳癌の長期予後 (第138回成医会総会一般演題)
15. A Case of Acute Exacerbation of Hepatitis B by Pembrolizumab for a Lung Adenocarcinoma Patient with Hepatitis B Surface Antigen
16. Biological properties of a specific Gαq/11 inhibitor, YM-254890, on platelet functions and thrombus formation under high-shear stress
17. YM-254890 analogues, novel cyclic depsipeptides with Gα q/11 inhibitory activity from Chromobacterium sp. QS3666
18. Progression of renal failure with anaemia and multiple effects of angiotensin-converting enzyme inhibitor in rats with renal mass reduction
19. CD3+, CD4–, CD8–, TCRαβ–, TCRγδ+ Granular Lymphocyte Proliferative Disorder without Lymphocytosis and Clinical Symptoms
20. Gemcitabine enhances rituximab-mediated complement-dependent cytotoxicity to B cell lymphoma by CD20 upregulation
21. Development of Rapid Debinding Treatment Using Superheated Steam and Debinding Behavior for Alumina Molded Bodies
22. Effects of gene polymorphisms on the risk of severe hyponatremia during DCF chemotherapy for patients with esophageal squamous cell carcinoma
23. Chemotherapy for alpha-fetoprotein producing gastric cancers expressing human epidermal growth factor receptor 2
24. Encryption of agonistic motifs for TLR4 into artificial antigens augmented the maturation of antigen-presenting cells
25. Theoretical framework regarding self-concept among hemodialysis patients in the prime of life
26. 要介護透析患者にかかわる家族介護者の在宅ケアの構造に関する研究
27. Additional file 1: Figure S1. of Up-regulation of HER2 by gemcitabine enhances the antitumor effect of combined gemcitabine and trastuzumab emtansine treatment on pancreatic ductal adenocarcinoma cells
28. Gemcitabine enhances rituximab‐mediated complement‐dependent cytotoxicity to B cell lymphoma by CD20 upregulation
29. Up-regulation of HER2 by gemcitabine enhances the antitumor effect of combined gemcitabine and trastuzumab emtansine treatment on pancreatic ductal adenocarcinoma cells
30. 壮年期血液透析患者のセルフケア・エージェンシーの発達に関する検討
31. A Research on the Facts of Hemodialysis Self-care in the Manhood stage
32. 災害時における救護活動の組織化に関する検討 (第一報)
33. 抗癌剤によるびまん性大細胞型B細胞性リンパ腫細胞のCD20発現増強とリツキシマブの抗腫瘍効果増強についての検討 (第132回成医会総会一般演題)
34. Expression of immune checkpoint molecules of T cell immunoglobulin and mucin protein 3/galectin-9 for NK cell suppression in human gastrointestinal stromal tumors
35. Combinatorial Contextualization of Peptidic Epitopes for Enhanced Cellular Immunity
36. Abstract CT223: Dendritic cells pulsed with Wilms′ tumor gene 1 (WT1)-specific and MHC class I and II-restricted epitopes with gemcitabine induce antitumor immune responses in patients with advanced pancreatic cancer
37. Abstract 1685: HER2 upregulation induced by gemcitabine treatment augments antitumor effect of trastuzumab emtansine against pancreatic cancer
38. ゲムシタビンによるHER2発現増強効果を利用した膵癌に対する新たな分子標的療法 (第131回成医会総会一般演題)
39. Treatment with Chemotherapy and Dendritic Cells Pulsed with Multiple Wilms' Tumor 1 (WT1)–Specific MHC Class I/II–Restricted Epitopes for Pancreatic Cancer
40. Enhanced apatite formation on Ti metal heated in PO2-controlled nitrogen atmosphere
41. 細胞性免疫を誘導する人工タンパク質ワクチンの開発 (第130回成医会総会一般演題)
42. Augmentation of Antitumor Immunity by Fusions of Ethanol-Treated Tumor Cells and Dendritic Cells Stimulated via Dual TLRs through TGF-β1 Blockade and IL-12p70 Production
43. Kidney disease: potential of anti-inflammatory approaches for drug therapy
44. A case of recurrent breast cancer suggesting chemotherapy affected the pain control with oxycodone
45. Current status of patients requiring daily life assistance among the hemodialysis patients managed at the hemodialysis centers in Ishikawa prefecture
46. Biological properties of a specific Gαq/11inhibitor, YM-254890, on platelet functions and thrombus formation under high-shear stress
47. Pharmacological properties of YM-254890, a specific Gαq/11 inhibitor, on thrombosis and neointima formation in mice
48. A Novel Gαq/11-selective Inhibitor
49. YM-254890 analogues, novel cyclic depsipeptides with Gαq/11 inhibitory activity from Chromobacterium sp. QS3666
50. Combined effects of a factor Xa inhibitor YM466 and a GPIIb/IIIa antagonist YM128 on thrombosis and neointima formation in mice
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.